ak 2123 has been researched along with Adenocarcinoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iakushchenko, TN; Kagiia, T; Konovalova, NP; Kotel'nikova, RA; Tat'ianenko, LV; Volkova, LM | 1 |
| Kagiya, TV; Konovalova, NP; Kotelnikova, RA; Tatyanenko, LV; Volkova, LM; Yakushchenko, TN | 1 |
| Afanasjev, S; Antipov, S; Cherdyntseva, N; Schepetkin, I; Zyryanov, B | 1 |
1 trial(s) available for ak 2123 and Adenocarcinoma
| Article | Year |
|---|---|
The luminol-amplified chemiluminescence of neutrophils and monocytes in patients with gastric cancer after intraoperative radiotherapy using radiosensitizer sanazole.
Topics: Adenocarcinoma; Aged; Female; Humans; Intraoperative Period; Luminescent Measurements; Luminol; Lymphoma, Non-Hodgkin; Male; Middle Aged; Monocytes; Neutrophil Activation; Neutrophils; Radiation-Sensitizing Agents; Stomach Neoplasms; Tetradecanoylphorbol Acetate; Triazoles | 1999 |
2 other study(ies) available for ak 2123 and Adenocarcinoma
| Article | Year |
|---|---|
[Inhibitory effect of the radiosensitizer AK-2123 on experimental liver metastasis and active transport of calcium ions].
Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Calcium Channel Blockers; Female; Fluorouracil; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Radiation-Sensitizing Agents; Time Factors; Triazoles | 1997 |
Inhibitory effect of radiosensitizer AK-2123 on experimental hepatic metastases and Ca2+ active transport.
Topics: Adenocarcinoma; Animals; Biological Transport, Active; Ca(2+) Mg(2+)-ATPase; Calcium; Colonic Neoplasms; Female; Liver Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Neoplasm Transplantation; Radiation-Sensitizing Agents; Triazoles | 1997 |